A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
Casgevy uses CRISPR/Cas9 gene-editing technology to modify a patient’s haematopoietic stem cells. Credit: Manjurul via Getty Images ... The therapy has a list price of £1.65m, and a commercial ...
Germ Cell Tumor Market Outlook 2025-2035: The 7 major germ cell tumor market reached a value of USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 4.2 Billion by 2035, ...
2022.09.002 3. Piao J, Lafin JT, Scarpini CG, et al. A multi-institutional pooled analysis demonstrates that circulating miR-371a-3p alone is sufficient for testicular malignant germ cell tumor ...
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1 + TAMs and CD8 + T cells
In addition to their previous report on directly targeting tumor cells via glucose transporter 1 (GLUT1), they tried to uncover additional working mechanisms of citalopram in HCC treatment in the ...
Please also check out our list of U.S. inverter manufacturing locations and our list of U.S. mounting manufacturers. Use the tabs above to view different groupings. *Some Made-in-America brands ...
To fill this knowledge gap, Ikeda and colleagues obtained tumour-infiltrating T cells and cancer cells from human tumours that were surgically removed and sequenced the mitochondrial DNA (mtDNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results